Iclusig

Manufacturing · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

40 Landsdowne St, Cambridge, Massachuset...

Phone Number

(844) 817-6468

Revenue

$7.9 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Iclusig

ICLUSIG is a prescription medicine designed for adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) and Chronic Myeloid Leukemia (CML). It is used in combination with chemotherapy in newly diagnosed Ph+ ALL and alone in adults with T315I-positive Ph+ ALL or certain phases of CML. ICLUSIG is not for newly diagnosed chronic phase CML patients. The product is intended for use in US patients only.Explore more
Iclusig's Social MediaPopular SearchesIclusigICLUSIG Dosing RegimensTakeda Pharmaceutical Company LtdSIC Code 28,283NAICS Code 32,325Show more

Is Iclusig your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Iclusig

Compare insights from companies similar to Iclusig, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Iclusig

$7.9M
11-50
Private
-
-
N/A
$5.9M
11-50
Private
-
2011
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Iclusig is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Iclusig is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Iclusig.

Iclusig Tech Stack

A closer look at the technologies used by Iclusig

Iclusig News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Iclusig

What is Iclusig's official website?
Iclusig's official website is www.iclusig.com
What is Iclusig's Revenue?
Iclusig's revenue is $7.9 Million
What is Iclusig's SIC code?
Iclusig's SIC: 28,283
What is Iclusig's NAICS code?
Iclusig's NAICS: 32,325
How many employees does Iclusig have?
Iclusig has 11-50 employees
What industry does Iclusig belong to?
Iclusig is in the industry of: Manufacturing, Pharmaceuticals
What is Iclusig competition?
Iclusig top competitors include: Cambia, Nexavar, Pomalyst, Pharmacyclics
What technology does Iclusig use?
Some of the popular technologies that Iclusig uses are: Drupal, reCAPTCHA, New Relic Browser, Brightcove
How do I contact Iclusig?
Iclusig contact info: Phone number: (844) 817-6468 Website: www.iclusig.com
What does Iclusig do?

ICLUSIG is a prescription medicine designed for adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) and Chronic Myeloid Leukemia (CML). It is used in combination with chemotherapy in newly diagnosed Ph+ ALL and alone in adults with T315I-positive Ph+ ALL or certain phases of CML. ICLUSIG is not for newly diagnosed ch... ronic phase CML patients. The product is intended for use in US patients only.Read More

What are Iclusig social media links?
Iclusig Linkedin page Iclusig Twitter page
Is Iclusig a public company?
Iclusig is private company therefore does not currently have an official ticker symbol
See more information about Iclusig

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.